Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nedjai, Belinda, Alvarez-Mendoza, Carlos, Powell, Ned, Tristram, Amanda and Jones, Sadie 2022. Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia. Cancer Biomarkers 35 , pp. 143-153. 10.3233/CBM-210448 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (992kB) | Preview |
Abstract
BACKGROUND: Topical cidofovir and imiquimod can effectively treat approximately 55% of patients with vulval intraepithelial neoplasia (VIN), thus avoiding the need for surgery. Human papillomavirus (HPV) E2 gene methylation predicts response to treatment but a methylation measurement is only obtainable in approximately 50% of patients. OBJECTIVE: This work aimed to determine if the applicability and predictive power of the E2 methylation assay could be improved by combining it with the components of a host and viral DNA methylation panel (S5) that has been found to predict disease progression in patients with cervical intraepithelial neoplasia. METHODS: HPV E2 methylation and S5 classifier score were measured in fresh tissue samples collected pre-treatment from 132 patients with biopsy-proven VIN grade 3 who participated in a multicentre clinical trial and were randomised to treatment with cidofovir or imiquimod. RESULTS: Combining HPV16 E2 and HPV16 L1 methylation provides a biomarker that is both predictive of response to topical treatment and that can produce a clinically applicable result for all patients. Patients with HPV 16 L1ℎ
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine Centre for Trials Research (CNTRR) |
Publisher: | IOS Press |
ISSN: | 1875-8592 |
Funders: | CRUK |
Date of First Compliant Deposit: | 31 August 2022 |
Date of Acceptance: | 24 June 2022 |
Last Modified: | 21 Oct 2023 01:07 |
URI: | https://orca.cardiff.ac.uk/id/eprint/152240 |
Actions (repository staff only)
Edit Item |